Published in Women's Health Weekly, July 6th, 2006
According to recent research published in the American Journal of Perinatology, "Infants born from mothers with antiphospholipid antibody (aPL)-positive autoimmune disease were prospectively evaluated for anticardiolipin and anti-beta 2 glycoprotein I antibodies (group 1) and for growth and neurological development."
"The results were compared with those obtained from two age-matched control groups (group 2 and 3)," wrote M. Motta and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly